
A novel inhibitor as therapeutic potential against pancreatic and hepatocellular cancers
This study reports a novel inhibitor oxide (MPO) which promotes inhibition of growth in pancreatic and hepatocellular cancer cell lines by inducing cell cycle arrest. Hence authors in this study




